Bayer Italia’s headquarters opens at Mind in Milan, where health becomes an ecosystem
Article excerpt
Rethinking the healthcare supply chain by starting afresh with the physical spaces in which to research, test and produce new medicines and launch innovative processes. With the push for extensive digitalisation now set aside, at least in part, workplaces – particularly in the life sciences sector – are once again proving as magnetic as ever. It may seem paradoxical, but in an era characterised by artificial intelligence and advanced predictive technologies, the sector has decided to put physicality back at the centre. That is, the sharing of spaces that act as catalysts for the future. An almost counter-intuitive yet necessary move to rethink shared offices and distributed laboratories, taking on new and necessarily multifaceted challenges linked to health. This is nothing new. As early as seven years ago – just a few months before the pandemic – scientific literature, particularly within the field of the Sociology of Health, was discussing ‘healing architecture’: healthcare spaces no longer viewed as mere containers, but as structures capable of influencing people’s wellbeing. A new frontier that originated in the most innovative hospitals and is now extending to laboratories, campuses and workplaces within the life sciences sector. Thus, in Milan, in the area known as Mind – which became a melting pot of cultures eleven years ago with the Expo – there is now the largest...
Keep reading with a free account
The rest of this article, and every signal for Bayer, is in your free account.
Extracted from this sentence
For the past few days, the district has been enriched by the new headquarters of Bayer, a pharmaceutical giant operating in the health and agriculture sectors with 88,000 employees worldwide and a turnover of over 45 billion euros, of which 5.8 billion is allocated to research and development.
